The cost of brand name drugs commonly prescribed to the elderly rose by an average of 7.4% last year, says the AARP, an increase that greatly exceeded inflation.
Also in the News for Thursday, Aug. 23
Aug 23, 2018
Conducting physical therapy in the emergency department after a fall may help to reduce future ED visits … Swapping brand-name drugs for generic combinations could save Medicare $1 billion …...
Medicaid pays too much for prescription drugs, OIG testifies
By
Haymarket Media
Dec 10, 2004
States can expect to take a closer look at the cost of prescription drugs after the Office of Inspector General said this week that Medicaid continues to overpay pharmacies for the drugs.
Baxter halts production of blood thinner
Feb 13, 2008
Baxter International has temporarily halted production of certain heparin vials amid reports of serious adverse reactions to the widely used, injectable blood thinner. Baxter has not broadened a prior...
Clinical Briefs for Thursday, January 2
By
Alicia Lasek
Jan 01, 2020
First generics of blood thinner Eliquis approved… FDA receives $91 million funding increase for 2020 … Few pharmacies provide antibiotic disposal instructions, survey shows
C. diff sources ‘diverse’: study
By
Tim Mullaney
Nov 01, 2013
New research challenges assumptions about how Clostridium difficile is transmitted.
Clinical Briefs for Monday, March 9
By
Alicia Lasek
Mar 08, 2020
Cognitive screening recommended for older adults in orthopedic rehab … Prioritize senior living residents in COVID-19-related funding: ASHA … Asthma drug Singulair and generic to get ‘black...
McKesson Alternate Site Pharmacy launches new program
Feb 23, 2016
McKesson Alternate Site Pharmacy℠ has debuted the PATH Pro™ Post-Acute Therapeutics Formulary Management Program for long-term care pharmacies.
Combining two drugs may help ameliorate Alzheimer’s symptoms
By
Haymarket Media
Jan 23, 2004
Two drugs that act differently on the brain’s chemistry worked in tandem to help ameliorate Alzheimer’s disease, researchers reported in the Journal of the American Medical Association.
Clinical Briefs for Thursday, August 6
By
Alicia Lasek
Aug 06, 2020
Proposed 9% cuts to therapy ‘potentially devastating’ … Medicare Part D favors generic drugs, say investigators … Novavax finds promising results in coronavirus vaccine trials … Bisphosphonates...